0001725160-24-000022.txt : 20240202 0001725160-24-000022.hdr.sgml : 20240202 20240202212851 ACCESSION NUMBER: 0001725160-24-000022 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240202 DATE AS OF CHANGE: 20240202 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Zentalis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001725160 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 823607803 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39263 FILM NUMBER: 24593706 BUSINESS ADDRESS: STREET 1: 1359 BROADWAY, SUITE 801 CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (212) 433-3791 MAIL ADDRESS: STREET 1: 1359 BROADWAY, SUITE 801 CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Zentalis Pharmaceuticals, LLC DATE OF NAME CHANGE: 20200107 FORMER COMPANY: FORMER CONFORMED NAME: Zeno Pharma, LLC DATE OF NAME CHANGE: 20171212 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Brownstein Carrie CENTRAL INDEX KEY: 0001894232 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 500 W. 5TH ST. STREET 2: SUITE 1200 CITY: AUSTIN STATE: TX ZIP: 78701 144 1 primary_doc.xml 144 0001894232 XXXXXXXX LIVE 0001725160 Zentalis Pharmaceuticals, Inc. 001-39263 1359 BROADWAY Suite 801 New York NY 10018 212-433-3791 Carrie Brownstein Former Chief Medical Officer Common Morgan Stanley Smith Barney LLC

1 New York Plaza, 38th Floor New York NY 10004

2059 23755.92 70928577 02/02/2024 NASDAQ Common 02/01/2024 Restricted Stock Unit Release Issuer N 2059 02/01/2024 NA Y The sale reported in this Form 144 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units. 02/02/2024 12/03/2022 /s/ Melissa Epperly, attorney-in-fact for Carrie Brownstein